Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia.
Rihwa ChoiInsuk SohnMin-Ji KimHye In WooJi Won LeeYoungeun MaEun Sang YiHong Hoe KooSoo-Youn LeePublished in: British journal of clinical pharmacology (2019)
Findings of this study may provide basic knowledge for personalized medicine for thiopurinxe treatment in paediatric acute lymphoblastic leukaemia patients.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- liver failure
- prognostic factors
- stem cells
- gene expression
- respiratory failure
- patient reported outcomes
- mesenchymal stem cells
- hepatitis b virus
- replacement therapy
- transcription factor
- mechanical ventilation
- acute respiratory distress syndrome
- genome wide identification